AstraZeneca to Acquire Alexion for US$ 39 Billion to Grow Immunology Pipeline
On December 12th, British pharma giant AstraZeneca announced that it has entered into a definitive agreement to acquire Boston-based Alexion Pharmaceuticals Inc., for a deal worth US$ 39 billion ($175 …
Read More